Melissa L.D. Christopher

ORCID: 0000-0001-9985-066X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Opioid Use Disorder Treatment
  • Pharmaceutical Practices and Patient Outcomes
  • Primary Care and Health Outcomes
  • Patient Satisfaction in Healthcare
  • Health Policy Implementation Science
  • Pain Management and Opioid Use
  • Substance Abuse Treatment and Outcomes
  • Musculoskeletal pain and rehabilitation
  • Health Sciences Research and Education
  • Rheumatoid Arthritis Research and Therapies
  • Cardiac Arrest and Resuscitation
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • Systemic Lupus Erythematosus Research
  • Posttraumatic Stress Disorder Research
  • Healthcare Systems and Technology
  • Schizophrenia research and treatment
  • HIV, Drug Use, Sexual Risk
  • Autoimmune and Inflammatory Disorders Research
  • Engineering Technology and Methodologies
  • Prenatal Substance Exposure Effects
  • Mental Health and Patient Involvement
  • Simulation-Based Education in Healthcare
  • Healthcare professionals’ stress and burnout
  • Veterinary medicine and infectious diseases

The University of Texas MD Anderson Cancer Center
2024

Veterans Health Administration
2018-2024

United States Department of Veterans Affairs
2019-2024

Positive Resource Center
2024

University of Colorado Anschutz Medical Campus
2024

Health Services Research & Development
2022

VA Rocky Mountain Network
2021

Office of Patient Care Services
2020

National Park Service
2020

Edith Nourse Rogers Memorial Veterans Hospital
2016

Active consideration of effective medications to treat alcohol use disorder (AUD) is a consensus standard care, yet knowledge and these are very low across diverse settings. This study evaluated the overall effectiveness multifaceted academic detailing program address this persistent quality problem in US Veterans Health Administration (VHA), as well context process factors that explained variation sites.An interrupted time series design, analyzed with mixed-effects segmented logistic...

10.1186/s13722-016-0063-8 article EN cc-by Addiction Science & Clinical Practice 2016-09-15

Background: Opioid use disorder (OUD) is a critical concern among US veterans. The Veterans Health Administration (VHA) recommends buprenorphine as first-line treatment for OUD; however, only 35% of veterans with an OUD currently receive medication treatment. Practical barriers, including the capacity providers to prescribe, may affect delivery buprenorphine. We examined current state within VHA. Methods: National VHA administrative databases were queried identify all credentialed prescribe...

10.1080/08897077.2018.1509251 article EN Substance Abuse 2018-07-01

Background: No previous studies exist examining the impact of a short-term pharmacist-endocrinologist collaborative practice model on glycemic control in complex patients. Objective: Evaluate outcomes associated with PharmD-Endocrinologist Diabetes Intense Medical Management (DIMM) “tune up” clinic for Methods: A retrospective cohort study 99 patients referred to DIMM versus comparator group 56 primary care provider (PCP) meeting same criteria (adult type 2 diabetes patients, glycosylated...

10.1177/1060028015615586 article EN Annals of Pharmacotherapy 2015-11-05

Abstract Objective Academic detailing in partnership with the Opioid Overdose Education and Naloxone Distribution (OEND) program was implemented to increase naloxone access for prevention of opioid overdose mortality veterans at U.S. Department Veterans Affairs (VA). However, implementation not uniform leading varying levels intervention exposure potentially impacting prescribing. We examined impact strength (proportion providers exposed academic detailing) each station on prescribing from...

10.1111/1475-6773.13194 article EN Health Services Research 2019-07-17

Abstract Objective To evaluate the cost‐effectiveness of intravitreal bevacizumab to ranibizumab in patients with neovascular age‐related macular degeneration (AMD). Methods A cost‐utility analysis using a Markov model was performed incremental ratio [ICER, $US per quality‐adjusted life year (QALY) gained] between and from US payer perspective. Transition probabilities for were extrapolated published studies local institutional data. Utility values, likewise, obtained another study....

10.1111/j.1365-2753.2010.01546.x article EN Journal of Evaluation in Clinical Practice 2010-09-16

Twenty to thirty percent of patients with schizophrenia experience treatment resistance. Clozapine is the only medication proven effective for treatment-resistant schizophrenia. However, in most settings less than 25% receive clozapine. This study was conducted identify facilitators and barriers clozapine use inform development interventions maximize appropriate utilization.Seventy semistructured phone interviews were key informants processes at U.S. Department Veterans Affairs medical...

10.1176/appi.ps.201500506 article EN Psychiatric Services 2016-06-15

As the coronavirus disease (COVID-19) pandemic continues its course in 2020, telehealth technology provides opportunities to connect patients and providers. Health policies have been amended allow easy access virtual health care, highlighting field's dynamic ability adapt a public crisis. Academic detailing, peer-to-peer collaborative outreach designed improve clinical decision-making, has traditionally relied on in-person encounters for effectiveness. A growth adoption of translates...

10.1016/j.japh.2020.06.028 article EN other-oa Journal of the American Pharmacists Association 2020-07-31

The aim was to measure patient satisfaction with the Pharmacy Specialty Immunization Clinic (PSIC), a pharmacist-run vaccination clinic.Patient measured using non-validated instrument containing 10 items five-point Likert scale (strongly agree, not sure, disagree and strongly disagree). Patients who were seen at PSIC received least one eligible take part in survey. Priority index, method used identify areas where limited resources can be maximize satisfaction, calculated for different of...

10.1211/ijpp.18.02.0005 article EN International Journal of Pharmacy Practice 2010-03-30

Academic detailing (AD) is a promising intervention to address the growing morbidity and mortality associated with opioids. While AD has been shown be effective in improving provider prescribing practices across range of conditions, it unclear how best implement AD. The present study was designed identify key lessons for implementation based on model program Veterans Health Administration (VA).Qualitative process evaluation using semistructured interviews.Seven VA health care systems Sierra...

10.1093/pm/pny085 article EN public-domain Pain Medicine 2018-04-07

Background Benzodiazepine use in the US Veterans Administration (VA) has been decreasing; however, a small number of veterans with posttraumatic stress disorder (PTSD) continue to receive benzodiazepine. Academic detailing, targeted-educational outreach intervention, was implemented at VA help reduce disparity between existing and evidence-based practices, including reduction benzodiazepine PTSD. Since evidence support national implementation academic detailing this clinical scenario scarce,...

10.1080/08897077.2019.1573777 article EN Substance Abuse 2019-03-14

Introduction: The seemingly inexorable rise of opioid-related overdose deaths despite the reduced number COVID-19 pandemic demands novel responses and partnerships in our public health system’s response. Addiction medicine is practiced a broad range siloed clinical environments that need to be included addiction training beyond traditional fellowship programs. Our objective this project was implement knowledge-based, live virtual program would provide clinicians other healthcare...

10.5811/westjem.17850 article EN cc-by Western Journal of Emergency Medicine 2024-05-20

Abstract Background The Veterans Health Administration (VHA) Opioid Safety Initiative (OSI) was implemented in 2013 and associated with a 25% relative decrease the dispensing of opioids. Although emergency department (ED) providers play role initiation continuation opioids, incumbent OSI did not target EDs. Objective goal this feasibility study to leverage existing VHA test novel ED‐based quality improvement (QI) program opioid prescribing multiple ED settings. Methods This...

10.1111/acem.13980 article EN Academic Emergency Medicine 2020-04-02

Clinical Practice Guidelines issued by the US Department of Veterans Affairs (VA) and Defense recommend prazosin for sleep/nightmares veterans with posttraumatic stress disorder (PTSD). As existing literature suggests this novel treatment option to be underutilized, we examined a cohort PTSD initiating characterize their typical duration use dosing patterns.Administrative data from fiscal year 2010 were used identify according ICD-9 codes extracted inpatient outpatient encounters. The...

10.4088/jcp.14m09057 article EN The Journal of Clinical Psychiatry 2015-05-27

Abstract Objectives To assess the process and outcomes of academic detailing to enhance Opioid Safety Initiative Psychotropic Drug reduce co-prescribing opioid-benzodiazepine combinations in veterans. Methods A retrospective cohort design was conducted evaluate impact implementing an program on between October 2014 through March 2019 at U.S. Department Veterans Affairs (VA). The primary outcome monthly prevalence veterans (number per 1,000 population) who were co-prescribed combination....

10.1093/pm/pnaa475 article EN public-domain Pain Medicine 2020-12-19

Abstract Purpose To provide a summary of the implementation virtual academic detailing pilot program at US Department Veterans Affairs (VA). Summary In September 2018, VA Pharmacy Benefits Management implemented (“e-Detailing”) across 3 regional networks. Academic involves multifaceted collaborative outreach delivered by trained healthcare clinicians to other using targeted educational interventions that improve clinical decision-making. Across VA, programs are primarily staffed specially...

10.1093/ajhp/zxac024 article EN public-domain American Journal of Health-System Pharmacy 2022-01-27
Coming Soon ...